Stripped of U.S. funding, the World Health Organization chief on Monday appealed to member countries to support its ...

JN.1 may not be more severe, but it spreads fast, and that’s reason enough to stay alert. Across Asia, the priority is clear: ...

In a world of increasing fragmentation and polarisation, the 78th World Health Assembly, starting Monday, will present itself ...

Singapore, Hong Kong, China, and Thailand are witnessing a spike in Covid-19 cases. In Singapore, the surge in infections is driven by LF.7 and NB.1.8 — both descendants of JN.1 variant, which is a ...

The World Health Organization on Monday opened its annual meeting of government ministers and other top envoys facing one of ...

Novavax shares surged more than 17% before the bell on Monday, following the long-delayed approval of its COVID-19 vaccine ...

The early months of Donald Trump’s presidency have brought sweeping changes to the country’s scientific and medical landscape ...

Høeg has been skeptical of the safety and value of some vaccines and mandates, raising questions about her approach at the ...

Gaithersburg’s Novavax has secured formal regulatory approval for its Covid vaccine. It's a major win, after the FDA delayed ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.

The U.S. Food and Drug Administration approved Novavax's COVIDd-19 vaccine with age restrictions after a six-week delay.